The World's First Blockchain-Based Healthcare Financial Solutions and Application Development Platform; HealthTech, Smart Capital, and Prime Brokerage Solutions Under One Umbrella.
Aenco is a blockchain based global financial solutions platform, combining decades of experience in traditional financial services and prime brokerage, with network of Healthcare technology (“HealthTech”) innovation partners and new-age applications, collectively developed under the umbrella “Aenco Global HealthTech Financial Solutions platform”.
What is special about Aenco?
Aenco is the world’s FIRST Blockchain based Healthcare Technology Financial Solutions Platform that leverages healthcare technologies with institutional financing, prime brokerage and smart capital solutions under one umbrella.
Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage and core smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.
Aenco will be combining its solutions platform and core financial ecosystem with the wider healthcare technology community, through the AEN token, as the key ecosystem building block and extensions across ALL its service and community deliveries.
The Aenco platform empowers emerging and innovative healthcare companies with digital financing capabilities, so that they can focus on generating high potential and impactful technologies that can transform our world and day to day lives.
Aenco is supported by the group’s planned regulated infrastructure (including the establishment of a commercial bank within the group) and presence in major jurisdictions including Europe, Hong Kong, and the United States, through which Aenco will effectively deliver its solutions, generating an increasing and rapidly evolving ecosystem.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
The economics of token is very unclear. It is explained that this is sort of membership reward token. But it still looks vague how the price could grow. I am not claiming to speak directly about such things in the whitepapers due to the well-known restrictions. But at least the project should add business numbers numbers about "ecosystem growth" in chapter 8 of the WP.
Team: Most of your advisors are not having a linked profile which make investors feel uncertain of their investment. Need to add more verified advisors to convince investors.
Vision: If you are doing this right as an ecosystem, it can be a good idea but I don't see it clearly stated in the whitepaper.
Product is vague as github does not considered a MVP as most of investors care about their ROI and having low tech knowledge.
ICO Advisor and Growth Hacker Rated on Jul 9, 2018
4
4
4
15%
I think the team is fairly strong and I like the vision. Supply chain in Health is critical.
The WhitePaper is not clear enough, but they they can change healthcare world.
Good idea, good team, well thought out, well done.
Crypto Investor | ICO Advisor | Token Sale Marketing | Private Sale Consultant Rated on Jul 13, 2018 Modified on Jul 13, 2018
5
5
5
4%
One of a few ICOs that builds and expands on an existing successful business in Fintech field. The core team has extensive and solid investment and capital background, plus the advisers are reputable in healthcare and medical fields, in the aspect of their research and technology innovation. That makes it a good-matched project combination of “when FinTech meets HealthTech”.
The Whitepaper is a bit complicated, to be honest, with layers of “not-so-easy-to-understand” stereoscopic concepts, proficient medical terms and sophisticated financial wordings, while this project is going to be managed and operated by trained professionals and industrial leaders, not amateurs, where it gains much confidence for investors.
Highly recommended ICO and an excellent Whitepaper!
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
Aeneas Capital grante Asset Management license by SFC (Hong Kong).
2
2008-2009
Fund products generate positive returns throughout subprime crisis.
3
4Q 2010
Assets managed by Aeneas deployed into health care private equity and direct investments.
4
2Q 2016
Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
5
3Q 2017
Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities;
Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
6
1Q 2018
Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress);
Aeneas Group establishing a full-service banking license in Europe (in progress).
7
2Q 2018
June Initiate Private Sale;
Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities;
Community investors outreach.
